Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players

被引:32
|
作者
de Jong, M. A. W. P. [1 ]
Geijtenbeek, T. B. H. [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands
关键词
human immunodeficiency virus-1; Langerhans cells; microbicide; mucosa; sexual transmitted infection; transmission; C-TYPE LECTIN; SEXUALLY-TRANSMITTED-DISEASES; CD8-ALPHA(+) DENDRITIC CELLS; NECROSIS-FACTOR-ALPHA; DC-SIGN; HIV-1; TRANSMISSION; CUTTING EDGE; EPIDEMIOLOGIC SYNERGY; TNF-ALPHA; INFECTION;
D O I
10.1111/j.1365-2796.2008.02046.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human immunodeficiency virus-1 (HIV-1) infection occurs primarily via genital mucosal tissues and the cellular mechanisms that affect HIV-1 acquisition are largely unclear. Langerhans cells (LCs) are professional antigen presenting cells lining the mucosal stratified squamous epithelium. It is becoming evident that LCs have different functions in HIV-1 transmission. HIV-1 can infect mucosal LCs, which subsequently efficiently transmit the virus to T cells in the lymphoid tissues. However, this seems to be dependent on the activation status of LCs, as immature LCs prevent HIV-1 infection by clearing invading HIV-1 though the C-type lectin langerin. Recent data demonstrate that co-infections with sexual transmitted infection (STIs) negate the protective function of LCs by different mechanisms, thereby allowing LC infection with HIV-1 and subsequently HIV-1 transmission. Here, we will discuss the function of LCs under normal circumstances and in the presence of STIs or inflammation. A better understanding of LCs function during homeostasis and inflammation is necessary for the development of new strategies to prevent HIV-1 infection.
引用
收藏
页码:18 / 28
页数:11
相关论文
共 50 条
  • [1] Aciclovir Treatment for Human Immunodeficiency Virus-1: Is the "Juice Worth the Squeeze?"
    Cohen, Myron S.
    Eron, Joseph J., Jr.
    SEXUALLY TRANSMITTED DISEASES, 2011, 38 (05) : 410 - 412
  • [2] Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2
    LeGoff, J.
    Roques, P.
    Jenabian, M. -A.
    Charpentier, C.
    Brochier, C.
    Bouhlal, H.
    Gresenguet, G.
    Frost, E.
    Pepin, J.
    Mayaud, P.
    Belec, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (09) : 873.e1 - 873.e9
  • [3] Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
    Introini, Andrea
    Vanpouille, Christophe
    Fitzgerald, Wendy
    Broliden, Kristina
    Margolis, Leonid
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (140):
  • [4] Genital Shedding of Resistant Human Immunodeficiency Virus-1 Among Women Diagnosed With Treatment Failure by Clinical and Immunologic Monitoring
    Graham, Susan M.
    Chohan, Vrasha
    Ronen, Keshet
    Deya, Ruth W.
    Masese, Linnet N.
    Mandaliya, Kishor N.
    Peshu, Norbert M.
    Lehman, Dara A.
    McClelland, R. Scott
    Overbaugh, Julie
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
  • [5] Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1
    McPherson, Tristan D.
    Sobieszczyk, Magdalena E.
    Markowitz, Martin
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 413 - 420
  • [6] Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines
    Andersen-Nissen, Erica
    Chang, Joanne T.
    Thomas, Katherine K.
    Adams, Devin
    Celum, Connie
    Sanchez, Jorge
    Coombs, Robert W.
    McElrath, M. Juliana
    Baeten, Jared M.
    SEXUALLY TRANSMITTED DISEASES, 2016, 43 (12) : 761 - 764
  • [7] Genotype and antiretroviral drug resistance of human immunodeficiency virus-1 in Saudi Arabia
    Jamjoom, Ghazi A.
    Azhar, Esam I.
    Madani, Tariq A.
    Hindawi, Salwa I.
    Bakhsh, Hanaa A.
    Damanhouri, Ghazi A.
    SAUDI MEDICAL JOURNAL, 2010, 31 (09) : 987 - 992
  • [8] Human natural killer cells in asymptomatic human immunodeficiency virus-1 Infection
    Hulström, AL
    Hejdeman, B
    Leandersson, AC
    Bratt, G
    Carbone, E
    Wahren, B
    INTERVIROLOGY, 2000, 43 (4-6) : 294 - 301
  • [9] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE
    TYAGI, SC
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1992, 70 (05): : 309 - 315
  • [10] A Lentiviral Vector That Activates Latent Human Immunodeficiency Virus-1 Proviruses by the Overexpression of Tat and That Kills the Infected Cells
    Macias, David
    Oya, Ricardo
    Saniger, Luisa
    Martin, Francisco
    Luque, Francisco
    HUMAN GENE THERAPY, 2009, 20 (11) : 1259 - 1268